YD Bio reported asset growth of 72.23% for the quarter ended Jun 2026. These growth metrics cover 2 quarters of results from Dec 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Dec2025 | Jun2026 |
|---|---|---|
| Growth Ratios | ||
| Assets Growth (1y) | 100.74% | 72.23% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 91.80% | 466.96% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -7.83% | -98.30% |